Skip to main content

Dr Reddy’s Labs Recalls 35,000 Tubes of Skin Infection Cream from US

Penelitian - Dr Reddy’s Laboratories’ US arm is recalling over 35,000 tubes of Nystatin and Triamcinolone Acetonide cream on account of failed stability specifications, USFDA said.

As per the US health regulator’s Enforcement Report, Dr Reddy’s Labs Inc is recalling 35,020 tubes of Nystatin and Triamcinolone Acetonide Cream, USP, 1,00,000 units/gm and 1 mg/gm from the American market.

Penelitian Dr Reddy’s Labs recalls 35,000 tubes of skin infection cream from US

The recall is on account of “failed stability specifications, an out of specification result was observed for the test parameter : composition of Nystatin during stability testing,” it added.

The cream is used for treatment of cutaneous candidiasis, a skin infection. The voluntary ongoing nationwide recall is a class II recall, United States Food and Drug Administration (USFDA) said.

As per USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.



Graphene Mechanical Pixels for Interferometric Modulator Displays

US Authorities Paves Way to Get Lab Meat on Plates

The Genetic Prehistory of the Andean Highlands 7000 Years BP Though European Contact

Spontaneous Innovation of Hook-bending and Unbending in Orangutans (Pongo abelii)

Late Middle Pleistocene Levallois Stone-tool Technology in Southwest China